InvestSMART

Integral Diagnostics Limited (ASX: IDX) - ETF Exposure

Current share price for IDX : $1.625 0.02 (1.22%)+

Integral Diagnostics (IDX) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It provides diagnostic services to patients and their referrers across Australia and New Zealand. IDX employs radiologists and diagnostic imaging specialists in a medical leadership model that ensures quality patient care, service, and access.

IDX General Information +

ASX Code IDX
Website N/A
Industry/Sector Health Care Services
Market Cap ($M) 607
IDX Share Price $1.625
Day High $1.653
Day Low $1.625
Last Close $1.645
IDX Share Price Movement $0.02 ( 1.22% )
Prices as at 16:40, 18 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to IDX

Integral Diagnostics Limited (IDX) is held across 16 ETFs spanning strategies that include health care services exposure . Its weighting in those funds means performance can have an outsized influence - when IDX moves, funds like IMPQ, MVS, ISO, SSO and MQAE that hold it can move with it.

For more concentrated exposure, ETFs such as IMPQ (eInvest Better Future (Managed Fund)) allocate about 1.5% to IDX , while the average exposure across all 16 ETFs that hold it is around 0.2% .

Top ETF holdings

Last updated: ETF data and holdings as at 17 November 2026

Own IDX directly or through an ETF?

How does holding Integral Diagnostics Limited (IDX) shares directly compare to ETFs that include it?

IDX Direct
IMPQ
ASX
MVS
ASX
ISO
ASX
SSO
ASX
MQAE
ASX
Holdings 1 company 42 holdings 91 holdings 220 holdings 220 holdings 241 holdings
IDX Weight 100% 1.5% 1.3% 0.2% 0.2% 0.1%
Diversification Single Stock Broad Broad Broad Broad Broad
Annual Cost Brokerage only - 0.49% p.a. 0.55% p.a. 0.5% p.a. 0.03% p.a.
Approx. Yield 4.7% - 3.07% 4.69% 9.91% 2.73%
Star Ratings - Not Rated starstarstar starstarstar starstar starstarstar

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not IDX's direct yield. Annual cost uses each ETF's MER.

IDX Exposure on $10,000 investment

How a $10,000 investment in Integral Diagnostics Limited (IDX) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Integral Diagnostics Limited (IDX) Direct share $1.625 -5.25% -$525 $9,475
eInvest Better Future (Managed Fund) (IMPQ) - $3.980 0% $0 $10,000
VanEck Small Companies Masters ETF (MVS) Equity - Australia Small/Mid Cap $19.550 -4.77% -$477 $9,523
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) Equity - Australia Small/Mid Cap $4.660 -5.48% -$548 $9,452
State Street SPDR S&P/ASX Small Ordinaries ETF (SSO) Equity - Australia Small/Mid Cap $13.530 -4.72% -$472 $9,528
Macquarie Core Australian Equity Active ETF (MQAE) Equity - Australia Strategy $11.960 -3.31% -$331 $9,669

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Integral Diagnostics Limited (IDX) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 6¢ 100% 28 Aug 2026 2 Oct 2026 - - -
Result 3.3¢ 100% 4 Mar 2026 2 Apr 2026 - - -
HFResult 4¢ 100% 29 Aug 2025 3 Oct 2025 - - -

See all dividends from Integral Diagnostics Limited (IDX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Integral Diagnostics Limited (IDX) price-sensitive announcements

IDX - AGM - Chair & CEO Presentations
Integral Diagnostics Limited’s 2026 AGM Chair and CEO presentations outlined strong FY26 p
Integral Diagnostics Limited (IDX)
29 Oct 2026 | 9:43 AM
IDX - FY26 Full Year Investor Presentation
Integral Diagnostics Limited's FY26 Full Year Investor Presentation highlights significant
Integral Diagnostics Limited (IDX)
25 Aug 2026 | 9:14 AM
IDX - FY26 Full Year Results Announcement
Integral Diagnostics Limited reported robust financial results for the fiscal year ending
Integral Diagnostics Limited (IDX)
25 Aug 2026 | 9:13 AM
IDX - FY26 Annual Report
In the FY26 Annual Report, Integral Diagnostics Limited (IDX) showcases significant financ
Integral Diagnostics Limited (IDX)
25 Aug 2026 | 9:13 AM

Integral Diagnostics Limited (IDX) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Integral Diagnostics Limited (IDX)
ORDINARY FULLY PAID
Health Care $607 Correction to App3Y - Andy Fay NED 4 Nov 2026 5:27PM $1.705 $1.625 fallen by 4.69%
Integral Diagnostics Limited (IDX)
ORDINARY FULLY PAID
Health Care $607 Change of Director's Interest Notice - Andy Fay NED 4 Nov 2026 2:31PM $1.695 $1.625 fallen by 4.13%
Integral Diagnostics Limited (IDX)
ORDINARY FULLY PAID
Health Care $607 Change in substantial holding 2 Nov 2026 5:33PM $1.760 $1.625 fallen by 7.67%
Integral Diagnostics Limited (IDX)
ORDINARY FULLY PAID
Health Care $607 Change of Director's Interest Notice - Jason Martinez CEO 2 Nov 2026 12:28PM $1.715 $1.625 fallen by 5.25%
Integral Diagnostics Limited (IDX)
ORDINARY FULLY PAID
Health Care $607 Change of Director's Interest Notice - Dr Kevin Shaw NED 30 Oct 2026 2:25PM $1.725 $1.625 fallen by 5.80%
Integral Diagnostics Limited (IDX)
ORDINARY FULLY PAID
Health Care $607 Results of Annual General Meeting 29 Oct 2026 3:20PM $1.808 $1.625 fallen by 10.10%

IDX Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2028F C2 $12.00 14.30% 13.70 7.00 4.30% 0.0%
2027F C2 $10.50 -19.50% 15.70 6.00 3.70% 0.0%
2026A $49.47 $13.10 70.40% 19.00 9.30 3.70% 100.0%

IDX Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2026 A 2027 F 2028 F 2026 A 2027 F 2028 F 2026 A 2027 F 2028 F
Australian Clinical Labs Limited (ACL) $625M 0.0442 0.0153 0.0417 17.7155 17.4479 16.7500 3.88% 4.03% 3.88%
Integral Diagnostics Limited (IDX) $617M 0.7037 -0.1954 0.1429 12.6437 15.7143 13.7500 5.64% 3.64% 4.24%
Sonic Healthcare Limited (SHL) $9,875M 0.2969 -0.1774 0.1040 14.4385 17.5525 15.8988 5.41% 5.26% 5.53%

IDX Directors

Name Position Start Date
Mr Jason Martinez Chief Executive Officer, Executive Director, Managing Director 6 Aug 2026
Mr Andrew James Fay Non-Executive Director 18 Jul 2022
Ms Ingrid Anne Player Non-Executive Director 29 Aug 2023
Ms Laura Nicole McBain Non-Executive Director 20 Dec 2024
Dr Kevin (Kai-Chung) Shaw Non-Executive Director 20 Dec 2024
Mr Manish Mittal Non-Executive Director 5 Feb 2025
Mr James Tobias Hall Non-Executive Director, Non-Executive Chairman 28 Sep 2023

Integral Diagnostics Limited (IDX) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
3 Nov 2026 FAY, Andrew Buy Indirect Shares 60,000 $1.728 $103,650.000
2 Nov 2026 MARTINEZ, Jason Buy Direct Shares 15,000 $1.760 $26,400.000
2 Oct 2026 HALL, James Issued Indirect Shares 5,868 $2.303 $13,516.181

See all changes in directors' interest & trades for Integral Diagnostics Limited (IDX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

IDX Management

Name Position
Craig White CFO
John J Merity Company Secretary

IDX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Integral Diagnostics Limited (IDX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
22,567,663 (6.05%) TAL Dai-ichi Life Australia Pty Ltd
21,200,856 (5.70%) Yarra Capital Management Limited
19,657,417 (5.28%) Lennox Capital Partners Limited
19,657,417 (5.28%) Challenger Limited
18,814,147 (5.05%) Vanguard Group (The Vanguard Group, Inc. and its controlled entities)
18,797,990 (5.04%) Wilson Asset Management Group
18,811,967 (5.04%) Australian Retirement Trust Pty LTD ATF Australian Retirement Trust
18,767,651 (5.03%) Tribeca Investment Partners Pty Ltd

IDX Calendar of Events

Date Event
24 August 2027 Report (Annual)
24 August 2027 Report (Prelim)
23 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.